Clinical Trials Logo

Filter by:
  • Suspended  
  • « Prev · Page [11]
NCT ID: NCT01000181 Suspended - Clinical trials for Carotid Atherosclerosis

Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

Start date: October 2012
Phase: N/A
Study type: Observational

The build up of plaque in the wall of the artery supplying blood to the brain poses a risk of stroke when the plaques become unstable and fragile. It is important to determine which patients are most at risk so that surgery can be performed. There is evidence that the risk is greatest when these plaques become oxygen deficient (hypoxic). The investigators wish to use PET imaging to identify hypoxic plaque, to help decide whether and when to perform surgery. The investigators have developed radiotracers (imaging agents) for this purpose, and this study is to determine whether they will work in patients.

NCT ID: NCT00940641 Suspended - Metabolism Clinical Trials

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

Start date: August 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of AZD7325 after intravenous and 14C labeled oral dose

NCT ID: NCT00038454 Suspended - Clinical trials for Cardiovascular Disease

Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate the efficacy of Hemolinkā„¢ in combination with Intraoperative Autologous Donation (IAD) versus control (IAD alone) in facilitating avoidance of allogeneic RBC transfusion during and following primary CABG surgery

NCT ID: NCT00003980 Suspended - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

BIBX 1382 in Treating Patients With Solid Tumors

Start date: February 1999
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BIBX 1382 in treating patients who have solid tumors.